TY - JOUR
T1 - Minimal clinical impact of embolization to new territory on outcomes in medium vessel occlusion strokes treated with mechanical thrombectomy
T2 - a retrospective multicenter study
AU - MAD MT
AU - Salim, Hamza Adel
AU - Yedavalli, Vivek
AU - Lakhani, Dhairya A.
AU - Milhem, Fathi
AU - Musmar, Basel
AU - Adeeb, Nimer
AU - Faizy, Tobias D.
AU - Daraghma, Motaz
AU - El Naamani, Kareem
AU - Henninger, Nils
AU - Sundararajan, Sri Hari
AU - Kuhn, Anna Luisa
AU - Khalife, Jane
AU - Ghozy, Sherief
AU - Scarcia, Luca
AU - Grewal, Inayat
AU - Yeo, Leonard L.L.
AU - Tan, Benjamin Y.Q.
AU - Regenhardt, Robert W.
AU - Heit, Jeremy Josef
AU - Cancelliere, Nicole M.
AU - Rouchaud, Aymeric
AU - Fiehler, Jens
AU - Sheth, Sunil A.
AU - Puri, Ajit S.
AU - Dyzmann, Christian
AU - Colasurdo, Marco
AU - Renieri, Leonardo
AU - Filipe, João Pedro
AU - Harker, Pablo
AU - Radu, Ră zvan Alexandru
AU - Abdalkader, Mohamad
AU - Klein, Piers
AU - Marotta, Thomas R.
AU - Spears, Julian
AU - Ota, Takahiro
AU - Mowla, Ashkan
AU - Jabbour, Pascal
AU - Biswas, Arundhati
AU - Clarençon, Frédéric
AU - Siegler, James E.
AU - Nguyen, Thanh N.
AU - Varela, Ricardo
AU - Baker, Amanda
AU - Essibayi, Muhammed Amir
AU - Altschul, David
AU - Gonzalez, Nestor
AU - Möhlenbruch, Markus A.
AU - Costalat, Vincent
AU - Wintermark, Max
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2026. No commercial re-use. See rights and permissions. Published by BMJ Group.
PY - 2026/1/1
Y1 - 2026/1/1
N2 - Background Mechanical thrombectomy (MT) is established as an effective treatment for large vessel occlusion strokes, but its efficacy and safety for medium vessel occlusions (MeVOs) remain less clear. This study examines the impact of periprocedural embolization to a new vascular territory (ENT) on clinical outcomes in patients with MeVO stroke treated with MT. Methods A multicenter, retrospective analysis was conducted using the MAD-MT (Multicenter Analysis of primary Distal medium vessel occlusions: effect of Mechanical Thrombectomy) registry, including 2122 patients with MeVO stroke w ho underwent MT between September 2017 and July 2023. ENT was defined as filling defects in previously unaffected territories, excluding embolization near the original occlusion, observed on final angiographic runs after retrieval of the primary thrombus. The associations between ENT, procedural variables, and 90-day clinical outcomes were evaluated, including functional independence (modified Rankin Scale (mRS) scores of 0-2), excellent outcomes (mRS 0-1), mortality, and hemorrhagic complications. Results ENT occurred in 2.9% (63/2122) of patients. Longer onset-to-arterial puncture time (adjusted OR 1.03; 95% CI 1.01 to 1.05; P=0.002) and a greater number of passes (adjusted OR 1.15; 95% CI 1.01 to 1.32; P=0.032) were associated with increased ENT risk, while excellent recanalization (thrombolysis in cerebral infarction (TICI) scale score 2c-3) was associated with reduced ENT risk (adjusted OR 0.41; 95% CI 0.23 to 0.72; P=0.002). ENT was not associated with poorer functional independence, mortality, or hemorrhagic complications. Conclusions ENT during MT for MeVO stroke occurs infrequently and does not significantly affect the clinical outcomes. These findings suggest ENT risk should not deter clinicians from performing MT in patients with MeVO. Further prospective studies are needed to validate these results.
AB - Background Mechanical thrombectomy (MT) is established as an effective treatment for large vessel occlusion strokes, but its efficacy and safety for medium vessel occlusions (MeVOs) remain less clear. This study examines the impact of periprocedural embolization to a new vascular territory (ENT) on clinical outcomes in patients with MeVO stroke treated with MT. Methods A multicenter, retrospective analysis was conducted using the MAD-MT (Multicenter Analysis of primary Distal medium vessel occlusions: effect of Mechanical Thrombectomy) registry, including 2122 patients with MeVO stroke w ho underwent MT between September 2017 and July 2023. ENT was defined as filling defects in previously unaffected territories, excluding embolization near the original occlusion, observed on final angiographic runs after retrieval of the primary thrombus. The associations between ENT, procedural variables, and 90-day clinical outcomes were evaluated, including functional independence (modified Rankin Scale (mRS) scores of 0-2), excellent outcomes (mRS 0-1), mortality, and hemorrhagic complications. Results ENT occurred in 2.9% (63/2122) of patients. Longer onset-to-arterial puncture time (adjusted OR 1.03; 95% CI 1.01 to 1.05; P=0.002) and a greater number of passes (adjusted OR 1.15; 95% CI 1.01 to 1.32; P=0.032) were associated with increased ENT risk, while excellent recanalization (thrombolysis in cerebral infarction (TICI) scale score 2c-3) was associated with reduced ENT risk (adjusted OR 0.41; 95% CI 0.23 to 0.72; P=0.002). ENT was not associated with poorer functional independence, mortality, or hemorrhagic complications. Conclusions ENT during MT for MeVO stroke occurs infrequently and does not significantly affect the clinical outcomes. These findings suggest ENT risk should not deter clinicians from performing MT in patients with MeVO. Further prospective studies are needed to validate these results.
KW - Hemorrhage
KW - Intervention
KW - Stroke
KW - Subarachnoid
KW - Thrombectomy
UR - https://www.scopus.com/pages/publications/105000308603
UR - https://www.scopus.com/pages/publications/105000308603#tab=citedBy
U2 - 10.1136/jnis-2024-022570
DO - 10.1136/jnis-2024-022570
M3 - Article
C2 - 40044412
AN - SCOPUS:105000308603
SN - 1759-8478
VL - 18
SP - 186
EP - 194
JO - Journal of neurointerventional surgery
JF - Journal of neurointerventional surgery
IS - 1
ER -